Pedro Mondejar-Lopez

Poster(s):

• (185) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating or residual function mutation
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET